why choose us

First received: November 06, 2023

Clinical Trial: An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: OBSERVATIONAL


Official Title: An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan

Brief Summary: This is an observational, cohort study that will use secondary data to describe the baseline demographics and clinical characteristics in patients who received EVUSHELD as PrEP against SARS-CoV-2 infection/COVID-19 in Japan.All patients who have a record of administration of EVUSHELD in the database will be included in the study.The index date will be defined as the date of first EVUSHELD administration in the database (Day 0) and the patients will be followed up to 6 months after the index date (Day 1 to…

Read more